Directory

NSCLC

NSCLC

Directory

[wpml_language_selector_widget]

NSCLC

Directory

Online resources

If you are looking for additional information, please explore these additional sites by following the links:

American Cancer Society
https://www.cancer.org/cancer/lung-cancer/about/what-is.html

American Thoracic Society

National Cancer Institute Non-Small Cell Cancer Treatment
https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq

Patient Toolkit

What exactly is NSCLC?

What symptoms can NSCLC cause?

How is NSCLC treated according to staging?

How is early NSCLC treated with surgery or SBRT?

When is chemotherapy used in NSCLC?

When is radiation used in NSCLC?

When is immunotherapy used in NSCLC?

When is targeted therapy used in NSCLC?

Online resources

This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2024 Med Learning Group. Built by Divigner. All Rights Reserved.

Scientific Council

Esta actividad es proporcionada por Med Learning Group. Esta actividad es co-proporcionada por Ultimate Medical Academy / Complete Conference Management (CCM).

Esta actividad está respaldada por una beca de educación médica independiente de Regeneron Pharmaceuticals, Inc.

Copyright © 2019 Med Learning Group. Construido por Divigner. Reservados todos los derechos.

Scientific Council

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Search

[divi_global_search_form]

Español

Retinopathy of Prematurity

Back to Portal
Scientific Council

Copyright © 2020 | ROP Relief | All Rights Reserved | Website by Divigner

Directory
Directory
Search
Search

Español

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

HD Visual Learning

  • Dynamic HD animations about ROP
  • Interactive, downloadable learning tools for mobile devices

Patient Toolkit

Patient Toolkit

Read more

What exactly is NSCLC?

What exactly is NSCLC?

Read more

What symptoms can NSCLC cause?

What symptoms can NSCLC cause?

Read more

How is NSCLC treated according to staging?

How is NSCLC treated according to staging?

Read more

How is early NSCLC treated with surgery or SBRT?

How is early NSCLC treated with surgery or SBRT?

Read more

When is chemotherapy used in NSCLC?

When is chemotherapy used in NSCLC?

Read more

When is radiation used in NSCLC?

When is radiation used in NSCLC?

Read more

When is immunotherapy used in NSCLC?

When is immunotherapy used in NSCLC?

Read more

When is targeted therapy used in NSCLC?

When is targeted therapy used in NSCLC?

Read more

Online resources

Online resources

Read more
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner